Kemwell boosts capacity with Sweden plant
Indian CMO Kemwell says new manufacturing plant in Sweden will help meet customer demand for European production capacity.
Indian CMO Kemwell says new manufacturing plant in Sweden will help meet customer demand for European production capacity.
BBK Worldwide and CROee take on Japan’s notorious “drug lag” with new partnership offering faster patient recruitment and trial site identification.
Pfizer plans to close eight manufacturing sites and reduce operations at a further six by the end of 2015, leading to 6,000 job losses, as part of its reorganisation after acquiring Wyeth.
Johnson Matthey is to manufacture the active pharmaceutical ingredient (API) in KP201, a pain drug developed by KemPharm, as part of a risk-and-reward sharing partnership.
Rumours have resurfaced that Indian generics firm Piramal Healthcare is in talks with Sanofi-Aventis and Pfizer about a potential takeover.
India and Thailand have requested the WHO ends its involvement with IMPACT, which the countries believe has conflicts of interest, and begin a programme focused on quality, safety and efficacy.
Encorium has posted a $1.9m (€1.6m) operating loss in the first quarter, with contract cancellations and reduced new business driving net revenues down by almost 34 per cent.